Paid Clinical Trials in New York, NY

As of June 2026, 3,489 paid clinical trials are recruiting in New York, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 8, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

3,489 clinical trials

↓ Download CSV

Alleviant ALLAY-HFrEF Study

for Heart Failure

35 locations incl. Los Angeles

Sponsor: Alleviant Medical, Inc.

Sex: All·Age: 18+

Code: NCT06812533·Enrolling By Invitation

Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.

for Lung Cancer Screening Program

1 location in New York

Sponsor: Physician Affiliate Group of New York

Sex: All·Age: 50 - 80·Accepts healthy volunteers

Code: NCT06876831·Recruiting

Apply to this trial

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration-Resistant Prostate Cancer

12 locations incl. Palo Alto

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT06879041·Phase 1·Recruiting

Apply to this trial

Parent-Child EF Intervention

for Cognitive Intervention to Promote Healthy Development of Executive Function (EF) Skills in Young Children

2 locations incl. Minneapolis

Sponsor: Koronis Biomedical Technologies

Sex: All·Age: 2 - 5·Accepts healthy volunteers

Code: NCT06924307·Recruiting

Apply to this trial

Prevention of Psychological Health Problems Via Integrated Operational Support

for Depression, Anxiety

1 location in New York

Sponsor: New York University

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06981598·Recruiting

Apply to this trial

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

for Antibody-Mediated Rejection

23 locations incl. Birmingham

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18 - 75

Code: NCT06744647·Phase 2·Recruiting

Apply to this trial

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

for HIV

13 locations incl. Birmingham

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT06812494·Phase 2·Recruiting

Apply to this trial

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

for Extramammary Paget's Disease

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female·Age: 18+

Code: NCT06873815·Phase 2·Recruiting

Apply to this trial

Improving Neck Control in Children With Cerebral Palsy Using Robotics

for Cerebral Palsy

2 locations incl. New York

Sponsor: Columbia University

Sex: All·Age: 11 - 21·Accepts healthy volunteers

Code: NCT06533293·Recruiting

Apply to this trial

A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid Tumors

for Locally Advanced or Metastatic Solid Tumors Harboring a ROS1 or NTRK Alteration

1 location in New York

Sponsor: Avistone Biotechnology Co., Ltd.

Sex: All·Age: 18+

Code: NCT06716138·Phase 1·Recruiting

Apply to this trial

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

for Advanced Hodgkin Lymphoma

5 locations incl. Irvine

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06745076·Phase 2·Recruiting

Apply to this trial

Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer

for Locally Advanced Triple Negative Breast Cancer

Drug: Dupilumab

1 location in New York

Sponsor: Rima Patel

Sex: All·Age: 18+

Code: NCT06637306·EARLY_Phase 1·Recruiting

Apply to this trial

Study of Circular RNA Treatment in Patients With Radiation Induced Xerostomia-1

for Radiation-Induced Xerostomia and Hyposalivation

4 locations incl. Iowa City

Sponsor: RiboX Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06714253·Phase 1, Phase 2·Recruiting

Apply to this trial

Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease

for APOL1-Mediated Kidney Disease

67 locations incl. Alabaster

Sponsor: AstraZeneca

Sex: All·Age: 18 - 65

Code: NCT06824987·Phase 2·Recruiting

Apply to this trial

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

for Cancer

12 locations incl. Orlando

Sponsor: Alterome Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06835569·Phase 1·Recruiting

Apply to this trial

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

for Anatomic Stage IV Breast Cancer AJCC v8

58 locations incl. Phoenix

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06500481·Phase 3·Recruiting

Apply to this trial

An Ophthalmic Safety Study in Patients With Breast Cancer

for Ophthalmic Safety in Patients With Breast Cancer

12 locations incl. La Jolla

Sponsor: AstraZeneca

Sex: All·Age: 18 - 130

Code: NCT06767462·Recruiting

Apply to this trial

Universal Genetic Testing for Cancer Risk Reduction

for Genetic Testing

1 location in New York

Sponsor: NYU Langone Health

Sex: Female·Age: 25 - 39·Accepts healthy volunteers

Code: NCT06926816·Recruiting

Apply to this trial

Temporal Interference Stimulation for Social Cognition

for Healthy Controls

1 location in New York

Sponsor: Columbia University

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT06607432·Recruiting

Apply to this trial

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for Chronic Kidney Disease and Hypertension

Drug: Dapagliflozin

132 locations incl. Fairhope

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06742723·Phase 3·Recruiting

Apply to this trial

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

for Major Depressive Disorder (MDD)

21 locations incl. Phoenix

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 18 - 65

Code: NCT06830044·Phase 3·Recruiting

Apply to this trial

Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment

for Non-small Cell Lung Cancer

Drug: Pumitamig

5 locations incl. Birmingham

Sponsor: BioNTech SE

Sex: All·Age: 18+

Code: NCT06841055·Phase 2·Recruiting

Apply to this trial

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

for Multiple System Atrophy

6 locations incl. Los Angeles

Sponsor: Dasher Neuroscience Inc.

Sex: All·Age: 30+

Code: NCT06848231·Phase 2·Recruiting

Apply to this trial

A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer

for Lung Cancer

7 locations incl. Basking Ridge

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All·Age: 18+

Code: NCT06863233·Phase 1·Recruiting

Apply to this trial

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for HER2-positive Gastric Cancer

Drug: Rilvegostomig

53 locations incl. Anchorage

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT06764875·Phase 3·Recruiting

Apply to this trial

Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis

for Primary Myelofibrosis

5 locations incl. Ann Arbor

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06517875·Phase 2·Recruiting

Apply to this trial

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

for Advanced Solid Tumor

21 locations incl. Scottsdale

Sponsor: Clasp Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06778863·Phase 1·Recruiting

Apply to this trial

Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib

for Hidradenitis Suppurativa (HS)

Drug: Povorcitinib

108 locations incl. Birmingham

Sponsor: Incyte Corporation

Sex: All·Age: 18+

Code: NCT06855498·Phase 3·Recruiting

Apply to this trial

Moms and Babies Health and Well-being

for Maternal and Child Health Outcomes

1 location in New York

Sponsor: Columbia University

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT06923371·Recruiting

Apply to this trial

Intervention INC: An Interactive Family-centered mHealth Tool to Reduce Obesity Risk in Urban Minority Preadolescents

for Obesity, Childhood

2 locations incl. New York

Sponsor: Tufts University

Sex: All·Age: 8 - 12·Accepts healthy volunteers

Code: NCT05935592·Recruiting

Apply to this trial

Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

for Hematopoietic and Lymphatic System Neoplasm

190 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: Female·Age: Up to 39

Code: NCT06513962·Phase 3·Recruiting

Apply to this trial

Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy

for Abnormal Uterine Bleeding

1 location in New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: Female·Age: 18+·Accepts healthy volunteers

Code: NCT06653400·Phase 1·Recruiting

Apply to this trial

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

for Gastric Cancer

18 locations incl. New Haven

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06731478·Phase 3·Recruiting

Apply to this trial

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

for Non-Small Cell Lung Cancer

Drug: Ivonescimab

89 locations incl. Chandler

Sponsor: Summit Therapeutics

Sex: All·Age: 18+

Code: NCT06767514·Phase 3·Recruiting

Apply to this trial

ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLC

for Solid Tumors

Drug: Amivantamab

2 locations incl. New York

Sponsor: ORIC Pharmaceuticals

Sex: All·Age: 18+

Code: NCT06816992·Phase 1·Recruiting

Apply to this trial

A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

9 locations incl. Orlando

Sponsor: NextCure, Inc.

Sex: All·Age: 18+

Code: NCT06792552·Phase 1·Recruiting

Apply to this trial

Gene Therapy for Alpha 1- Antitrypsin Deficiency

for Alpha 1-Antitrypsin Deficiency

1 location in New York

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: 18 - 70

Code: NCT06996756·Phase 1·Recruiting

Apply to this trial

Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness

for MEF2C

1 location in New York

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: All ages

Code: NCT07413211·Recruiting

Apply to this trial

Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive Disorder

for Major Depressive Disorder

1 location in New York

Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All·Age: 21 - 80

Code: NCT06592833·Phase 2·Recruiting

Apply to this trial

Mobile Cognitive Behavioral Therapy for Stroke

for Anxiety

1 location in New York

Sponsor: Weill Medical College of Cornell University

Sex: All·Age: 40 - 79

Code: NCT06689878·Recruiting

Apply to this trial